BGA/11/15
Sponsored by Anna Kate Autry, Will Carroll, Malvika Singh, Andrew Tomchuk of Webb School
The delegates above represented the Delegation of Lao Peoples Democratic Republic.
This legislation was filed in the Social, Humanitarian and Cultural category
Presented as part of the MUN B 2023 conference
| 1 | The General Assembly, |
| 2 | |
| 3 | Acknowledging that around 2/3 of Laos is rural area, being one of the less developed countries in |
| 4 | the world; |
| 5 | |
| 6 | Understanding that the leading causes of death are pneumonia and influenza, along with other |
| 7 | diseases due to lack of access to vaccinations; |
| 8 | |
| 9 | Recognizing that Laos has an estimated 0.4 doctors per one thousand people as of 2020; |
| 10 | |
| 11 | Making note that the majority of healthcare facilities, including public hospitals, are located |
| 12 | primarily on the borders of the country, giving no access for those in rural parts of the country; |
| 13 | |
| 14 | Noticing that because of the lack of medical help availability, the ability to be vaccinated for |
| 15 | diseases (not including COVID-19) are limited for the majority of the people; |
| 16 | |
| 17 | Keeping in mind that the healthcare in Laos is significantly underdeveloped in combating modern |
| 18 | day diseases; |
| 19 | |
| 20 | Noting that most pharmaceutical businesses in the country are unlicensed and unlawfully selling |
| 21 | their products with false advertisements, further increasing the lack of proper help and aid towards |
| 22 | illnesses; |
| 23 | |
| 24 | Understanding that the PDR does not have properly equipped or educated people to run medical |
| 25 | facilities to contribute to the curing of various illnesses across the country. |
| 26 | |
| 27 | The delegation of the Lao People’s Democratic Republic hereby: |
| 28 | |
| 29 | Calls upon the United Nations to aid the PDR in creating more public hospitals on the inner parts of |
| 30 | the country, giving more access for people in need of medical assistance |
| 31 | |
| 32 | Requests funding for the training and administration of appropriate drug distributions and medical |
| 33 | needs, as well as various disease control costs. |
| 34 | |
| 35 |